IBio Appoints Evert Schimmelpennink to the Board of Directors
June 09, 2021 at 04:30 pm EDT
iBio, Inc. announced the appointment of Evert (Eef) Schimmelpennink to its Board of Directors, effective immediately. In an executive leadership career spanning more than 20 years, Mr. Schimmelpennink has applied his strategic and functional expertise across corporate development, commercial operations, manufacturing, and R&D to help build and scale a number of global public and private biopharmaceutical businesses. Recently, he served as CEO of Pfenex Inc.